NADIN MANSOUR
Allopathic & Osteopathic Physicians|Pediatrics RIVERSIDE, CA NPI 1144648908
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics CA Verrica Pharmaceuticals Inc. All categories
General Payments — all program years on this page
$234.44
- Category: General Payments
- Program years: PY2023–2024
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $165.79 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $165.79 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Verrica Pharmaceuticals Inc. | $63.75 | 3 |
| SANOFI PASTEUR INC. | $29.66 | 1 |
| GlaxoSmithKline, LLC. | $22.71 | 1 |
| Merck Sharp & Dohme Corporation | $17.32 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.04 | 1 |
| Cranial Technologies, Inc | $15.31 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1082219430 | Cranial Technologies, Inc | $15.31 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116455153 | GlaxoSmithKline, LLC. | $22.71 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118383798 | Verrica Pharmaceuticals Inc. | $23.66 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118383800 | Verrica Pharmaceuticals Inc. | $16.52 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118383802 | Verrica Pharmaceuticals Inc. | $23.57 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1128754241 | SANOFI PASTEUR INC. | $29.66 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139942715 | SANOFI-AVENTIS U.S. LLC | $17.04 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141915981 | Merck Sharp & Dohme LLC | $17.32 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.